Investors
Share price
{{priceData.date}} {{priceData.time}}
{{'2024-10-18T09:32:29Z' | dateFormatFilter}}
Novo Nordisk A/S: Alhemo® recommended for European approval as first once-daily subcutaneous prophylactic treatment for people living with haemophilia A or B with inhibitors
Read more
{{'2024-10-08T08:00:44Z' | dateFormatFilter}}
Novo Nordisk launches new initiative to prevent childhood obesity in disadvantaged urban communities
Read more
{{'2024-09-20T12:43:15Z' | dateFormatFilter}}
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed
Read more
Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.